Fidelity Investments’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2M | Buy |
122,966
+117,544
| +2,168% | +$2.08M | ﹤0.01% | 2639 |
|
|
2025
Q4 | $101K | Buy |
5,422
+703
| +15% | +$11.7K | ﹤0.01% | 3748 |
|
|
2025
Q3 | $68.9K | Sell |
4,719
-194
| -4% | -$2.45K | ﹤0.01% | 3827 |
|
|
2025
Q2 | $54.2K | Buy |
4,913
+2,522
| +105% | +$24.5K | ﹤0.01% | 3862 |
|
|
2025
Q1 | $21.4K | Sell |
2,391
-10,085
| -81% | -$93.8K | ﹤0.01% | 4204 |
|
|
2024
Q4 | $117K | Buy |
12,476
+10,005
| +405% | +$91K | ﹤0.01% | 3478 |
|
|
2024
Q3 | $19.9K | Buy |
2,471
+886
| +56% | +$7.67K | ﹤0.01% | 4180 |
|
|
2024
Q2 | $13.4K | Sell |
1,585
-585
| -27% | -$5.28K | ﹤0.01% | 4222 |
|
|
2024
Q1 | $19.5K | Sell |
2,170
-10,891
| -83% | -$101K | ﹤0.01% | 4029 |
|
|
2023
Q4 | $147K | Sell |
13,061
-2,840
| -18% | -$28.6K | ﹤0.01% | 3058 |
|
|
2023
Q3 | $137K | Sell |
15,901
-948,923
| -98% | -$9.16M | ﹤0.01% | 2997 |
|
|
2023
Q2 | $9.99M | Sell |
964,824
-749,565
| -44% | -$8.28M | ﹤0.01% | 1865 |
|
|
2023
Q1 | $18.6M | Sell |
1,714,389
-759,083
| -31% | -$8.03M | ﹤0.01% | 1633 |
|
|
2022
Q4 | $27.8M | Sell |
2,473,472
-66,815
| -3% | -$702K | ﹤0.01% | 1488 |
|
|
2022
Q3 | $25.8M | Sell |
2,540,287
-158,063
| -6% | -$1.48M | ﹤0.01% | 1529 |
|
|
2022
Q2 | $24.4M | Buy |
2,698,350
+3,438
| +0.1% | +$31.7K | ﹤0.01% | 1573 |
|
|
2022
Q1 | $25.8M | Buy |
2,694,912
+106,531
| +4% | +$1.04M | ﹤0.01% | 1672 |
|
|
2021
Q4 | $28.6M | Sell |
2,588,381
-82,500
| -3% | -$719K | ﹤0.01% | 1654 |
|
|
2021
Q3 | $19.8M | Sell |
2,670,881
-8,120,982
| -75% | -$90.8M | ﹤0.01% | 1851 |
|
|
2021
Q2 | $157M | Buy |
10,791,863
+1,061,697
| +11% | +$19.9M | 0.01% | 915 |
|
|
2021
Q1 | $199M | Buy |
9,730,166
+188,372
| +2% | +$3.58M | 0.02% | 792 |
|
|
2020
Q4 | $170M | Buy |
9,541,794
+70,172
| +0.7% | +$1.26M | 0.02% | 820 |
|
|
2020
Q3 | $140M | Buy |
9,471,622
+64,092
| +0.7% | +$1.2M | 0.01% | 783 |
|
|
2020
Q2 | $197M | Buy |
9,407,530
+42,086
| +0.4% | +$1.08M | 0.02% | 618 |
|
|
2020
Q1 | $216M | Buy |
9,365,444
+906,787
| +11% | +$22.7M | 0.03% | 483 |
|
|
2019
Q4 | $219M | Buy |
8,458,657
+106,383
| +1% | +$2.07M | 0.02% | 617 |
|
|
2019
Q3 | $163M | Buy |
8,352,274
+74,979
| +0.9% | +$1.51M | 0.02% | 689 |
|
|
2019
Q2 | $135M | Buy |
8,277,295
+82,246
| +1% | +$1.67M | 0.02% | 799 |
|
|
2019
Q1 | $186M | Buy |
8,195,049
+25,234
| +0.3% | +$640K | 0.02% | 675 |
|
|
2018
Q4 | $209M | Buy |
8,169,815
+46,071
| +0.6% | +$1.24M | 0.03% | 577 |
|
|
2018
Q3 | $265M | Buy |
8,123,744
+42,240
| +0.5% | +$1.15M | 0.03% | 562 |
|
|
2018
Q2 | $183M | Buy |
8,081,504
+8,493
| +0.1% | +$202K | 0.02% | 701 |
|
|
2018
Q1 | $196M | Buy |
8,073,011
+119,527
| +2% | +$3.28M | 0.02% | 691 |
|
|
2017
Q4 | $222M | Buy |
7,953,484
+48,586
| +0.6% | +$1.44M | 0.03% | 647 |
|
|
2017
Q3 | $271M | Buy |
7,904,898
+59,645
| +0.8% | +$1.95M | 0.03% | 566 |
|
|
2017
Q2 | $313M | Buy |
7,845,253
+1,000,823
| +15% | +$38.5M | 0.04% | 492 |
|
|
2017
Q1 | $252M | Buy |
6,844,430
+1,276,794
| +23% | +$40.8M | 0.03% | 592 |
|
|
2016
Q4 | $177M | Buy |
5,567,636
+1,537,310
| +38% | +$47.7M | 0.02% | 730 |
|
|
2016
Q3 | $146M | Buy |
4,030,326
+752,111
| +23% | +$20.9M | 0.02% | 807 |
|
|
2016
Q2 | $74.4M | Buy |
3,278,215
+1,358,912
| +71% | +$29.3M | 0.01% | 1103 |
|
|
2016
Q1 | $36.1M | Buy |
1,919,303
+122,493
| +7% | +$2M | 0.01% | 1386 |
|
|
2015
Q4 | $29.4M | Buy |
1,796,810
+1,674,391
| +1,368% | +$26.6M | ﹤0.01% | 1488 |
|
|
2015
Q3 | $1.34M | Buy |
122,419
+100,049
| +447% | +$1.27M | ﹤0.01% | 2486 |
|
|
2015
Q2 | $291K | Sell |
22,370
-2,200
| -9% | -$34.1K | ﹤0.01% | 2667 |
|
|
2015
Q1 | $426K | Hold |
24,570
| – | – | ﹤0.01% | 2635 |
|
|
2014
Q4 | $367K | Sell |
24,570
-274,378
| -92% | -$4.78M | ﹤0.01% | 2685 |
|
|
2014
Q3 | $6.89M | Sell |
298,948
-233,722
| -44% | -$6.78M | ﹤0.01% | 2134 |
|
|
2014
Q2 | $17M | Buy |
+532,670
| New | +$16M | ﹤0.01% | 1870 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
